Funder
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Subject
Toxicology,General Medicine
Reference61 articles.
1. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease;Agostini;mBio,2018
2. Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence;Lin;Infection,2021
3. Safety, tolerability, and pharmacokinetics of remdesivir, an antiviral for treatment of COVID-19, in healthy subjects;Humeniuk;Clin. Transl. Sci.,2020
4. Pharmacokinetic, pharmacodynamic, and drug-interaction profile of remdesivir, a SARS-CoV-2 replication inhibitor;Humeniuk;Clin. Pharmacokinet.,2021
5. Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic;Pashaei;Drug Discov. Ther.,2021
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献